Faraday Future Announced a Total Strategic Investment of $41 million in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) During its Annual 919 Event, for its Crypto Business Focusing on Three Growth Engines
Faraday Future founder and Global Co-CEO YT Jia is seen presenting Company updates, including details on the Strategic Investment of $41 million in Qualigen Therapeutics, Inc. (NASDAQ: QLGN), at the Company's recent 919 Futurist Day & Stockholders’ Community Day, held at the Company's Los Angeles headquarters.
Format
JPEG
Source
Faraday Future